Dee Sparacio: QI Initiative Reduces Venous Thromboembolism in First-Line Ovarian Cancer Care
Dee Sparacio, Research Advocate, shared a post on X about a recent article by Limor Helpman et al., published in Gynecologic Oncology, adding:
“Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project; gyncsm oral anticoagulation QI program successfully decreased VTE events during first-line chemotherapy for OC.”
Title: Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer– A quality improvement project
Authors: Limor Helpman, Dana Josephy, Liat Toderis, Victoria Tkach, Noa Rotem, Daniel Shai, Sonya Bar-Adon, Hadas Heger, Yfat Kadan, Ana Blecher, Orgad Rosenblatt, Itai Yagel, Danielle Mor-Hadar, Keren Levanon, Ronnie Shapira-Frommer, Akram Saad, Smadar Bauer, Sara Apter, Tima Davidson, Aaron Lubetsky, Jacob Korach

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments